Genpact vs Paychex
G and PAYX side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How G and PAYX compare
Paychex is the larger company, worth 5.6 times as much as Genpact ($41.2B against $7.3B).
On earnings, Genpact is cheaper: it trades at 12.7× trailing earnings, against 23.0× for Paychex.
Paychex grew revenue faster over the last twelve months (14.0% versus 6.7% for Genpact).
Paychex keeps more of each dollar of sales as profit, with a net margin of 27.4% compared with 11.0% at Genpact.
Both pay dividends: Genpact yields 1.3% and Paychex 4.0%.
Genpact scores higher on the StockData Score (21 against 19 for Paychex), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | G | PAYX |
|---|---|---|
| Size and price | ||
| Market cap | $7.3B | $41.2B |
| Share price | $43.61 | $115.68 |
| Change, 1 year | −4.2% | 4.1% |
| Change, 5 years | −14.1% | −7.4% |
| Beta (5Y) | 0.65 | 0.75 |
| Employees | 147K | 18K |
| StockData Score | ||
| Total score | 21 (better) | 19 |
| Valuation score | 5 (better) | 4 |
| Growth score | 3 | 3 |
| Performance score | 6 (better) | 3 |
| Health score | 4 | 4 |
| Dividend score | 3 | 5 (better) |
| Valuation | ||
| P/E | 12.7× (better) | 23.0× |
| P/S | 1.4× (better) | 6.2× |
| P/B | 2.7× (better) | 11.1× |
| EV/EBITDA | 10.0× (better) | 14.8× |
| P/FCF | 20.6× | 20.4× (better) |
| PEG | 0.69 (better) | 5.24 |
| FCF yield | 4.9% | 4.9% (better) |
| Fair value | $57.11 | $123.43 |
| Margin of safety | 23.6% (better) | 6.3% |
| Growth | ||
| Revenue growth (TTM) | 6.7% | 14.0% (better) |
| Revenue growth, 5Y average | 6.5% | 9.9% (better) |
| Net income growth (TTM) | 6.7% | 11.9% (better) |
| EPS growth (TTM) | 10.6% | 13.3% (better) |
| EPS growth, 5Y average | 14.8% (better) | 10.0% |
| Profitability | ||
| Gross margin | 36.9% | 74.4% (better) |
| Operating margin | 14.9% | 39.2% (better) |
| Net margin | 11.0% | 27.4% (better) |
| FCF margin | 6.7% | 30.5% (better) |
| Return on equity | 22.4% | 47.1% (better) |
| Return on invested capital | 19.1% | 26.9% (better) |
| Financial health | ||
| Debt / equity | 0.43 (better) | 1.23 |
| Net debt / EBITDA | 0.85 (better) | 1.20 |
| Interest coverage | – | 9.7× |
| Current ratio | 1.95 (better) | 1.28 |
| Altman Z-score | 3.55 (better) | 3.33 |
| Piotroski F-score | 7 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 1.3% | 4.0% (better) |
| Payout ratio | 21.0% | 90.0% |
| Years of dividend growth | 6 | 15 (better) |
| Dividend growth, 5Y average | 11.8% | 11.9% (better) |
| Buyback yield | – | 1.1% |
| Shareholder yield | 1.3% | 5.1% (better) |
| Ownership | ||
| Held by institutions | 107% | 83.3% |
| Held by insiders | 35.7% | 10.2% |
| Insider net buying, 12 months | −$4.0M (better) | −$4.4M |
| Superinvestors holding | 1 | 2 (better) |
| Short interest, % of float | 9.9% | 6.2% |
Go deeper
- G stock overview
- G income statement
- G valuation and score
- PAYX stock overview
- PAYX income statement
- PAYX valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.